Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA) announced its participation in the 36th Annual Piper Sandler Healthcare Conference. CEO John Butler will lead a Fireside Discussion on December 3rd at 10:30 AM EST. The conference is scheduled for December 3-5, 2024 in New York. A webcast of the presentation will be available on Akebia's investor relations website for six months following the event. Akebia focuses on developing treatments for people affected by kidney disease.

News Market Reaction – AKBA

+2.66%

+2.66% Session move

In the trading session that priced this news, AKBA gained 2.66%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Nov. 25, 2024 /PRNewswire/ -- Akebia Therapeutics^®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a Fireside Discussion at the 36^th Annual Piper Sandler Healthcare Conference on Tuesday, December 3^rd at 10:30 AM EST.

A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 6 months following the conference.

The Piper Sandler Healthcare Conference will take place December 3-5, 2024 in New York.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-36th-annual-piper-sandler-healthcare-conference-302315009.html

SOURCE Akebia Therapeutics, Inc.

FAQ

When is Akebia Therapeutics (AKBA) presenting at the Piper Sandler Healthcare Conference 2024?

Akebia Therapeutics will present on Tuesday, December 3rd, 2024 at 10:30 AM EST during the Piper Sandler Healthcare Conference.

How long will the AKBA Piper Sandler Conference webcast be available?

The webcast will be available for 6 months following the conference through Akebia's investor relations website.

Where can I watch Akebia Therapeutics' (AKBA) Piper Sandler Conference presentation?

The presentation webcast can be accessed through the 'Investors' section of Akebia's website at https://ir.akebia.com

What type of presentation will AKBA give at the Piper Sandler Healthcare Conference?

Akebia's CEO John Butler will participate in a Fireside Discussion at the conference.